Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Spineway : First-quarter 2025 revenue of €2.8 million
-
Mobee Partners with ATT Global to Launch Exclusive IEO Platform and Drive Web3 Innovation
-
New Spiritual Guide GRACEFUL NOTES AND LETTERS Unlocks Life’s Potential Through God’s Grace
-
Weekly share repurchase program transaction details
-
COCA-COLA COMMITS TO DIAMANTE SPONSORS FOR HSF’S 50th ANNIVERSARY CELEBRATION & LEADERS IN EDUCATION AWARDS
-
COCA-COLA COMMITS TO DIAMANTE SPONSORS FOR HSF’S 50th ANNIVERSARY CELEBRATION & LEADERS IN EDUCATION AWARDS
-
CORRECTION NOTICE: Stride Announces Date for Third Quarter Fiscal Year 2025 Earnings Call
-
Good Game Reality Show Reimagines Global Gaming Stardom with Tokenized Memberships and Real-Life Lounges
-
GTX Solutions Expands Its Customer Data Consulting Services to Meet Growing Demand
-
Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million
-
Graze Raises $1M to Take Back Social Media from Algorithmic Control
-
Press release - SPIE signs an agreement to acquire LTEC Group in poland
-
NOTICE OF ANNUAL GENERAL MEETING IN TERRANET AB
-
Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
-
Arkos360® Care Management Platform Achieves HITRUST r2 Certification Demonstrating the Highest Level of Information Protection Assurance
-
Quadient Recognized in Analyst Report on Top AI Use Cases for Finance Automation
-
Quadient Recognized in Analyst Report on Top AI Use Cases for Finance Automation
-
Cherry AI: A Revenue-Backed Infrastructure Layer Positioned for a Breakout IDO
-
Cherry AI: A Revenue-Backed Infrastructure Layer Positioned for a Breakout IDO
-
HII Leader is Elected to Executive Committee of the Information Warfare Research Project Consortium
-
Dr. Sud Agarwal Leads iNGENu CRO in Launching Groundbreaking Clinical Trials for Sleep Disorders Following Ethics Approval
-
Transaction in Own Shares
-
SmartCentres Declares Distribution for April 2025
-
RTI to Exhibit and Speak at DeviceTalks Boston 2025
-
Fifty Governments Stand Firm on the Drive for Economic Resilience
-
The Link Builder Unveils New Blog Article on Enhancing SEO with Press Releases
-
Molecular Partners Announces all Board Proposals Approved at Annual General Meeting
-
Publication of the 2024 Universal Registration Document
-
The Board of Directors has resolved to carry out directed issues of units totaling approximately SEK 25 million and a fully underwritten rights issue of units of approximately SEK 15 million
-
Purchase of Own Securities and Total Voting Rights
-
LONG BEACH CITY COLLEGE WINS NATIONAL AWARD FOR ADVANCING INSTITUTIONAL EQUITY AND BELONGING
-
Common Diesel DEF Problems and How to Solve Them
-
Porsche 911 Carrera GTS wins 2025 World Performance Car award
-
New Self-Help Book AMERICAN DREAM⎯IT’S WAITING FOR YOU Offers Roadmap to Success at Any Stage of Life
-
Backyard Discovery Introduces New Outdoor Patio Products Just in Time for Summer
-
Sonoco Increases Quarterly Common Stock Dividend
-
AGCO issues $120,000 penalty to Great Canadian Casino Resort Toronto for cheat scheme involving two dealers
-
SMCP - 2024 Universal registration document available
-
Ascom Annual General Meeting approves all proposals of the Board of Directors
-
Valneva to Participate in Multiple Events at the 25th World Vaccine Congress, including a Presentation on its Chikungunya Vaccine IXCHIQ®
-
Nexity: Availability of the 2024 Universal registration document
-
Early Warning Press Release
-
Changes in Nokia Corporation's own shares
-
NextNav Announces Appointment of H. Wyman Howard and Lorin Selby to its Board of Directors
-
Changes in Nokia Corporation's own shares
-
DEME announces start of new share buyback program
-
MG Collectibles and Toys Partners with NPC Labs and Spaciom to Authenticate and Monetize Collectibles with Cutting-Edge Technology
-
Hub Cyber Security Appoints Shlomo Bibas as an Independent Member of the Board of Directors
-
Coppergate Global, National Corporate Housing’s Destination Services Division, Wins 2024 Graebel Partner Alliance Excellence Award
-
BlueRock Therapeutics announces publication in Nature of 18-month data from Phase 1 clinical trial for bemdaneprocel, an investigational cell therapy for Parkinson’s disease

